1 Min Read
April 30 (Reuters) - Capricor Therapeutics Inc:
* CAPRICOR ANNOUNCES INITIATION OF HOPE-2 CLINICAL TRIAL OF CAP-1002 FOR DUCHENNE MUSCULAR DYSTROPHY Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.